Evidence map›Paper›PMID 30691509›Full record

ArticleJournal of experimental & clinical cancer research : CR2019

Tobacco smoke induced hepatic cancer stem cell-like properties through IL-33/p38 pathway.

Chunfeng Xie, Jianyun Zhu, Xueqi Wang, Jiaqi Chen, Shanshan Geng, Jieshu Wu, Caiyun Zhong, Xiaoting Li

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Potential Harm of IQOS Smoke to Rat Liver.International journal of molecular sciences · 2023
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Oxidative medicine and cellular longevity · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. BioMed research international · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Chunfeng XieDepartment of Toxicology and Nutritional Science, School of Public Health, Nanjing Medical University, 101 Longmian Ave, Jiangning, Nanjing, 211166, Jiangsu, China.
Jianyun ZhuSuzhou Digestive Diseases and Nutrition Research Center, North District of Suzhou Municipal Hospital, The Affiliated Suzhou Hospital of Nanjing Medical University, No. 242 Guangji Road, Suzhou, 215008, Jiangsu, China.
Xueqi WangDepartment of Toxicology and Nutritional Science, School of Public Health, Nanjing Medical University, 101 Longmian Ave, Jiangning, Nanjing, 211166, Jiangsu, China.
Jiaqi ChenDepartment of Toxicology and Nutritional Science, School of Public Health, Nanjing Medical University, 101 Longmian Ave, Jiangning, Nanjing, 211166, Jiangsu, China.
Shanshan GengDepartment of Toxicology and Nutritional Science, School of Public Health, Nanjing Medical University, 101 Longmian Ave, Jiangning, Nanjing, 211166, Jiangsu, China.
Jieshu WuDepartment of Toxicology and Nutritional Science, School of Public Health, Nanjing Medical University, 101 Longmian Ave, Jiangning, Nanjing, 211166, Jiangsu, China.
Caiyun ZhongDepartment of Toxicology and Nutritional Science, School of Public Health, Nanjing Medical University, 101 Longmian Ave, Jiangning, Nanjing, 211166, Jiangsu, China. cyzhong@njmu.edu.cn.
Xiaoting LiDepartment of Toxicology and Nutritional Science, School of Public Health, Nanjing Medical University, 101 Longmian Ave, Jiangning, Nanjing, 211166, Jiangsu, China. xiaotingli@njmu.edu.cn.
Nanjing Medical University · CN

Funding

National Natural Science Foundation of China No. 81602839, 81773431, 81573139, 81803210Natural Science Foundation of Jiangsu Province BK20161029, SBK2018041176Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)
6 · The paper itself

Abstract

backgroundTobacco smoke (TS) critically contributes to the development of hepatocellular carcinoma. Cancer stem cells (CSCs) induced by TS is an early event in the initiation of carcinogenesis. Tumor specific microenvironment including inflammatory factors is key mediator for maintaining the stemness of CSCs through various pathways such as p38 MAPK. However, the mechanisms of inflammatory factors in TS-induced acquisition of liver CSCs properties remain undefined. The aim of this study was to investigate the role of IL-33/p38 axis in long term TS-induced acquisition of hepatic CSCs properties in mouse liver tissues and human liver cells.

methodsBALB/c mice were exposed to TS for 12 weeks, along with or without 1 mg/kg SB203580 (p38 inhibitors) treatment. Histopathological analysis, alterations in the levels of IL-33, liver CSCs markers, EMT-like changes and p38 MAPK activation in liver tissues of mice were analyzed by immunohistochemical staining, immunofluorescence assay and Western blot analysis. Moreover, LO2 immortalized human liver cells were exposed to cigarette smoke extract (CSE) and the tumorsphere formation ability was determined. LO2 cells were further treated with IL-33 or CSE and the expression of phosphorylated p38, liver CSCs markers and EMT-related proteins was examined.

resultsLong term TS exposure increased the levels of CSCs markers, induced epithelial-to mesenchymal transition (EMT) and inflammatory factor IL-33 expression. Moreover, we showed that p38 MAPK modulated TS-stimulated hepatic CSC-like properties, as evidenced by the findings that long term TS exposure activated p38, and that TS-induced stemness was abolished by p38 inhibition. In addition, data from in vitro model showed that similar to cigarette smoke extract (CSE), IL-33 treatment promoted the activation of p38, increased the levels of liver CSCs markers expression and EMT-like changes.

conclusionsCollectively, these data suggested that IL-33/p38 axis plays an important role in long term TS exposure-induced acquisition of hepatic CSC-like properties.

Indexed as

Epithelial-Mesenchymal TransitionAnimalsApoptosisCell ProliferationCell Transformation, NeoplasticHumansInterleukin-33Liver Neoplasms, ExperimentalMaleMiceMice, Inbred BALB CNeoplastic Stem Cellsp38 Mitogen-Activated Protein KinasesPhosphorylationSignal TransductionTumor Cells, CulturedIL33 protein, humanInterleukin-33p38 Mitogen-Activated Protein KinasesEMTIL-33Liver CSCsp38 MAPKTobacco smoke

Identifiers

PMID30691509
PMCPMC6350284
OpenAlexW2947492318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.